Elevated levels of testosterone and C-reactive protein (CRP) have been associated with an increased risk of breast cancer, whereas higher levels of sex hormone-binding globulin (SHBG) correlate with a reduced risk [17,18]. This evidence concerns the gene SHBG and breast carcinoma.